Giovanni A Chiariello, Emmanuel Villa, Piergiorgio Bruno, Annalisa Pasquini, Marialisa Nesta, Francesco Ferraro, Serena D'Avino, Valerio Sanesi, Claudia Vecchio, Antonio Messina, Margherita Dalla Tomba, Maria Calabrese, Abdallah Raweh, Luca Montini, Giovanni Troise, Massimo Massetti
BACKGROUND: The increasing use of biological substitutes for surgical aortic valve replacement (AVR), has led to the development of new bioprostheses with improved hemodynamics and expected durability. METHODS: In this observational retrospective two-center cohort study, two innovative bioprostheses, INSPIRIS Resilia and AVALUS were analyzed. We analyzed early and 2.4-year follow-up results in terms of safety, clinical outcome and hemodynamic performance. RESULTS: From November 2017 to February 2021, 148 patients underwent AVR with INSPIRIS Resilia (N...
June 2023: Journal of Cardiovascular Surgery